- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06924814
Technology-Based Distractions for Minor Procedures
August 16, 2026 updated by: Thomas Caruso, Stanford University
The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset, Augmented Reality Headset) are more effective than the standard of care (i.e., no technology-based distraction) for decreasing anxiety and pain scores in pediatric patients undergoing various minor procedures (i.e lumbar punctures and cardiac catheterization).
The anticipated primary outcome will be a reduction of overall cumulative medication and secondary outcomes include but are not limited to: physician satisfaction, discharge time, pain scores, anxiety scores, and procedure time.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Lucile Packard Children's Hospital Stanford
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Pediatric patient age between 4-17
- English speaking
- Parental consent/patient assent
- Undergoing minor procedure(s) at LPCH or Stanford Hospital
Exclusion Criteria:
- Patient does not consent
- Legal guardian not present to obtain consent
- Patient with a significant neurological condition or major developmental disability
- Patient experiencing nausea
- Patient with active infection of the face or hand
- A history of severe motion sickness
- A history of visual problems
- A history of seizures caused by flashing light
- Major surgery within the last 48 hours
- Patients who are clinically unstable or require urgent/emergent intervention
- Patient or parental preference for general anesthesia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard of Care group
No immersive technology will be assigned to the participant.
Participant will use their own distraction method.
|
Participant is allowed to use what they will use as a distraction tool while they are receiving treatment.
|
|
Experimental: Immersive Technology grorup
Immersive technologies including VR headsets, a bluetooth haptic device (Buddy Guard), a screen and projector (BERT), and a tablets with a game will be randomly assigned to the participants.
Each participant will receive one technological intervention.
|
Participants will be randomly assigned to one of the following four groups; VR headsets, a bluetooth haptic device (Buddy Guard), a screen and projector (BERT), and a tablets with a game.
Participant's anxiety will be assessed and pre- and post-intervention assessments will be completed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the effectiveness of technological interventions on anxiety levels in patients who undergo minor procedures
Time Frame: baseline, immediately after the intervention
|
Participants will complete the Visual Analogue Scale for Anxiety (VAS-A), a self-report scale to measure anxiety levels before and after the technological intervention.
The scale is a horizontal line from 0 to 10 with an anchor at 0 indicating "no anxiety" and an anchor at 10 indicating "worst possible anxiety".
|
baseline, immediately after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluate the effectiveness of technological interventions on pain levels in patients whose age is 4-11 years old and undergo minor procedures
Time Frame: baseline, immediately after the intervention
|
The FSP-R is a self-report measure of pain intensity displaying six faces representing equal intervals between the scale values from least pain = 0 to most pain = 10
|
baseline, immediately after the intervention
|
|
To evaluate pain levels pre- and post-intervention, participants will complete the Numerical Rating Pain Scale (NRPS) for patients 12-17 years old.
Time Frame: baseline, immediately after the intervention
|
The NRPS quantifies pain intensity on a scale from 0, being no pain, to 10, being the worst imaginable pain.
|
baseline, immediately after the intervention
|
|
To evaluate patient's, clinician's, and caregiver's satisfaction levels
Time Frame: immediately after the intervention
|
To analyze the patient's, clinician's, and caregiver's satisfaction levels, the feedback in the satisfaction survey at the end will be evaluated.
The purpose of this analysis is to provide qualitative data on which aspects of the technological intervention the patient received mattered the most to the patient, clinician, and caregiver.
|
immediately after the intervention
|
|
To evaluate the patient's affect during the intervention using HRAD
Time Frame: during minor procedure
|
HRAD contains 5-item scale assessing participant's affective state; happy, relaxed, anxious, distressed, with a yes/no answer to cooperation.
|
during minor procedure
|
|
To evaluate the patient's cooperation during the intervention using the modified Induction Compliance Checklist (mICC)
Time Frame: during minor procedure
|
The mICC score will be recorded by the trained research observers during the minor procedure.11
behaviors that are commonly observed preoperatively will be recorded.
Perfect compliance (score of 0) was compared to those that lacked cooperation.
mICC will be rated at the time of intervention and only requires one RA.
|
during minor procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2026
Primary Completion (Estimated)
April 30, 2027
Study Completion (Estimated)
April 30, 2027
Study Registration Dates
First Submitted
April 4, 2025
First Submitted That Met QC Criteria
April 4, 2025
First Posted (Actual)
April 11, 2025
Study Record Updates
Last Update Posted (Actual)
August 18, 2026
Last Update Submitted That Met QC Criteria
August 16, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 80120
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.